According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful… [ Get More Details ]
A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment… [ Get More Details ]
An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay… [ Get More Details ]
An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer… [ Get More Details ]
From 2007 to 2011, lung cancer incidence rates decreased by three percent each year in men and 2.2 percent each year in women.
[ Get More Details ]